ICL Group Ltd. Files December 2025 6-K Report

Ticker: ICL · Form: 6-K · Filed: Dec 23, 2025 · CIK: 941221

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, routine-filing

TL;DR

ICL Group Ltd. (ICL) filed its monthly 6-K report on Dec 23, 2025.

AI Summary

ICL Group Ltd. filed a Form 6-K on December 23, 2025, reporting for the month of December 2025. The company, formerly known as Israel Chemicals Ltd., is based in Tel Aviv, Israel, and operates in the agriculture chemicals sector. This filing is a routine report for a foreign private issuer.

Why It Matters

This filing provides routine updates for investors and regulators regarding ICL Group Ltd.'s activities as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate a change in risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country or that it has filed or will file with a stock exchange.

When was ICL Group Ltd. formerly known as?

ICL Group Ltd. was formerly known as Israel Chemicals Ltd.

What is the primary business sector of ICL Group Ltd.?

ICL Group Ltd. operates in the AGRICULTURE CHEMICALS sector, with a Standard Industrial Classification code of 2870.

Where is ICL Group Ltd.'s principal executive office located?

ICL Group Ltd.'s principal executive office is located at Millennium Tower, 23 Aranha Street, P.O. Box 20245, Tel Aviv, Israel.

Does ICL Group Ltd. file annual reports under Form 20-F or 40-F?

ICL Group Ltd. files annual reports under cover of Form 20-F.

Filing Stats: 2,268 words · 9 min read · ~8 pages · Grade level 20 · Accepted 2025-12-23 06:11:43

Key Financial Figures

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-13742 ICL GROUP LTD. (Exact name of registrant as specified in its charter) ICL Group Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F ICL GROUP LTD. The information contained in this Report on Form 6-K (including the presentation attached hereto) shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company's filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing. ICL GROUP LTD. 1. Investor Presentation This presentation will be used in connection with upcoming meetings with investors and is therefore being filed so all investors have access. Item 1 Important legal notes Disclaimer and safe harbor for forward-looking "estimate," "strive," "forecast," "targets" and "potential," among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements. Forwardlooking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the company intent, belief or current expectations. Forwardlooking statements are based on the company management's beliefs and assumptions and on information currently available to the company management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forwardlooking statements due to various factors, including, but not limited to: our ability to implement the strategic changes we are outlining in this presentation; changes in exchange rates or prices compared to those we are currently experiencing; the effects of the ongoing security situation in Israel, including the nature and duration of related conflicts; loss or impairment of business licenses or mineral extractions permits or concessions including our ability to win the new concession at the Dead Sea in 2030; volatility of supply and demand and the impact of competition; the difference between actual reserves and the company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to harvest salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the company seaport shipping facilities or regulatory restrictions affecting the company ability to export the company products overseas; general market, political or economic conditions in the countries in which the company operates, including tariffs and trade policies; price increases or shortages with respect to the company principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the company plants; labor disputes, slowdowns and strikes involving the company employees; pension and health insurance liabilities; disruptions from pandemics that may impact the company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the company, or the company service providers', information technology systems or breaches of the company, or the company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the company businesses; changes in d

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing